D
Daniel F. Sahm
Researcher at University of Chicago
Publications - 229
Citations - 11854
Daniel F. Sahm is an academic researcher from University of Chicago. The author has contributed to research in topics: Broth microdilution & Biology. The author has an hindex of 54, co-authored 184 publications receiving 11181 citations. Previous affiliations of Daniel F. Sahm include Icahn School of Medicine at Mount Sinai.
Papers
More filters
Journal ArticleDOI
Prevalence in the United States of aac(6′)-Ib-cr Encoding a Ciprofloxacin-Modifying Enzyme
TL;DR: Aac(6′)-Ib-cr was geographically widespread, stable over time, most common in Escherichia coli, equally prevalent in ciprofloxacin-susceptible and -resistant strains, and not associated with qnr genes.
Journal ArticleDOI
qnr Prevalence in Ceftazidime-Resistant Enterobacteriaceae Isolates from the United States
TL;DR: ABSTRACT The authors screened 313 ceftazidime-resistant Enterobacteriaceae isolates obtained in the United States from 1999 to 2004 for all three known qnr genes and found qnrA and qnrB occurred with equivalent frequencies and, except for qnrS, were stable over time.
Journal ArticleDOI
Relationships between Enterococcal Virulence and Antimicrobial Resistance
TL;DR: The virulence of enterococci is reviewed, as distinct from the acquisition of antimicrobial resistance genes, and current gaps in the understanding of enteringococcal virulence and the basis for disease are identified.
Journal ArticleDOI
Trends in Antimicrobial Resistance among Urinary Tract Infection Isolates of Escherichia coli from Female Outpatients in the United States
TL;DR: National resistance rates to SXT were relatively consistent but demonstrated considerable regional and institutional variation in 2001, and Therapies other than SXT may need to be considered in some locations.
Journal ArticleDOI
Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States
TL;DR: Prevalence of MRSA among both inpatient and outpatient specimens continues to increase with multi-drug resistance as a common phenotype, which has important implications for developing and evolving outpatient treatment guidelines.